2.71
Finanzdaten der Eledon Pharmaceuticals Inc-Aktie (ELDN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
|
37.68%
24.73
|
17.96 | 24.70 | 20.51 | 14.50 |
Operating Income/Loss |
37.68%
-24.73
|
-17.96 | - | -20.51 | -14.50 |
Income/Loss From Continuing Operations Before Tax |
72.69%
-11.22
|
-6.495 | -44.19 | 76.97 | -44.91 |
Income/Loss From Continuing Operations After Tax |
72.69%
-11.22
|
-6.495 | -44.62 | 76.97 | -44.91 |
|
72.69%
-11.22
|
-6.495 | -44.62 | 76.97 | -44.91 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | -2.882 | 22.54 | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.04%
77.16
|
77.13 | 7.1007 | 51.95 | 42.28 |
Diluted Average Shares |
0.04%
77.16
|
77.13 | 5.437 | 55.48 | 42.28 |
Basic Earnings Per Share |
62.50%
-0.13
|
-0.08 | -0.88 | 1.05 | -1.06 |
Diluted Earnings Per Share |
62.50%
-0.13
|
-0.08 | 0.67 | -0.32 | -1.06 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | -5.764 | 45.08 | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):